news
El Financiero
2026-08-29
Moderna's mRNA Cancer Vaccine Shows Promising Phase 3 Results
Using technology developed during the COVID-19 pandemic, Moderna and Merck's mRNA vaccine has shown positive results in reducing the recurrence of aggressive melanoma.